•
Sep 30, 2015

Jazz Pharmaceuticals Q3 2015 Earnings Report

Total Revenue
$341M
Previous year: $307M
+11.2%
EPS
$2.52
Previous year: $2.33
+8.2%
Gross Profit
$312M
Previous year: $280M
+11.8%
Cash and Equivalents
$999M
Previous year: $575M
+73.7%
Total Assets
$3.46B
Previous year: $3.35B
+3.5%

Jazz Pharmaceuticals

Jazz Pharmaceuticals